"Drugmaking boosts" Swaziland economy
At a ceremony marking the opening of a new pharmaceutical plant and the 10th anniversary of Mchepa Chemical Industries, the King of Swaziland said that drug manufacturing is a boost to the local economy.
Mchepa's main customer is the Swaziland government, as well as privately-owned pharmacies and clinics, according to a report in the Swazi Observer. Importing drugs is an expense, noted King Mswati III, and having a domestic industry not only saves on this cost, but also boosts the economy by creating jobs. He also called on Mchepa's management to buy and use local raw materials to further boost the domestic economy.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze